共 17 条
[11]
Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis
[J] .
Vasilios G Athyros,Konstantinos Tziomalos,Thomas D Gossios,Theodora Griva,Panagiotis Anagnostis,Konstantinos Kargiotis,Efstathios D Pagourelias,Eleni Theocharidou,Asterios Karagiannis,Dimitri P Mikhailidis.  The Lancet .
2010
[12]
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
[J] .
Naveed Sattar,David Preiss,Heather M Murray,Paul Welsh,Brendan M Buckley,Anton JM de Craen,Sreenivasa Rao Kondapally Seshasai,John J McMurray,Dilys J Freeman,J Wouter Jukema,Peter W Macfarlane,Chris J Packard,David J Stott,Rudi G Westendorp,James Shepherd,Barry R Davis,Sara L Pressel,Roberto Marchioli,Rosa Maria Marfisi,Aldo P Maggioni,Luigi Tavazzi,Gianni Tognoni,John Kjekshus,Terje
[15]
Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial
[J] .
Haruo Nakamura,Kikuo Arakawa,Hiroshige Itakura,Akira Kitabatake,Yoshio Goto,Takayoshi Toyota,Noriaki Nakaya,Shoji Nishimoto,Masaharu Muranaka,Akira Yamamoto,Kyoichi Mizuno,Yasuo Ohashi.  The Lancet .
2006
(9542)
[16]
Atherosclerotic plaque regres-sion:fact or fiction
.2
Shanmugam N,Román-Rego A,Ong P,et al. Cardiovasc Drugs Ther
. 2010
[17]
Effect of two intensivestatinregimensonprogressionofcoronarydisease
.2
Nicholls SJ,Ballantyne CM,Barter PJ,et al. NEnglJMed
. 2011